Matches in Wikidata for { <http://www.wikidata.org/entity/Q45282927> ?p ?o ?g. }
- Q45282927 description "2013 nî lūn-bûn" @default.
- Q45282927 description "2013年の論文" @default.
- Q45282927 description "2013年学术文章" @default.
- Q45282927 description "2013年学术文章" @default.
- Q45282927 description "2013年学术文章" @default.
- Q45282927 description "2013年学术文章" @default.
- Q45282927 description "2013年学术文章" @default.
- Q45282927 description "2013年学术文章" @default.
- Q45282927 description "2013年學術文章" @default.
- Q45282927 description "2013年學術文章" @default.
- Q45282927 description "2013年學術文章" @default.
- Q45282927 description "2013年學術文章" @default.
- Q45282927 description "2013年學術文章" @default.
- Q45282927 description "2013년 논문" @default.
- Q45282927 description "article científic" @default.
- Q45282927 description "article scientific" @default.
- Q45282927 description "article scientifique" @default.
- Q45282927 description "articol științific" @default.
- Q45282927 description "articolo scientifico" @default.
- Q45282927 description "artigo científico" @default.
- Q45282927 description "artigo científico" @default.
- Q45282927 description "artigo científico" @default.
- Q45282927 description "artikel ilmiah" @default.
- Q45282927 description "artikull shkencor" @default.
- Q45282927 description "artikulong pang-agham" @default.
- Q45282927 description "artykuł naukowy" @default.
- Q45282927 description "artículo científico publicado en 2013" @default.
- Q45282927 description "artículu científicu" @default.
- Q45282927 description "bilimsel makale" @default.
- Q45282927 description "bài báo khoa học" @default.
- Q45282927 description "naučni članak" @default.
- Q45282927 description "scienca artikolo" @default.
- Q45282927 description "scientific article published in June 2013" @default.
- Q45282927 description "scientific article published in June 2013" @default.
- Q45282927 description "scientific article published in June 2013" @default.
- Q45282927 description "teaduslik artikkel" @default.
- Q45282927 description "tieteellinen artikkeli" @default.
- Q45282927 description "tudományos cikk" @default.
- Q45282927 description "vedecký článok" @default.
- Q45282927 description "vetenskaplig artikel" @default.
- Q45282927 description "videnskabelig artikel" @default.
- Q45282927 description "vitenskapelig artikkel" @default.
- Q45282927 description "vitskapeleg artikkel" @default.
- Q45282927 description "vědecký článek" @default.
- Q45282927 description "wetenschappelijk artikel" @default.
- Q45282927 description "wissenschaftlicher Artikel" @default.
- Q45282927 description "επιστημονικό άρθρο" @default.
- Q45282927 description "мақолаи илмӣ" @default.
- Q45282927 description "наукова стаття, опублікована в червні 2013" @default.
- Q45282927 description "научна статия" @default.
- Q45282927 description "научная статья" @default.
- Q45282927 description "научни чланак" @default.
- Q45282927 description "научни чланак" @default.
- Q45282927 description "מאמר מדעי" @default.
- Q45282927 description "مقالة علمية نشرت في يونيو 2013" @default.
- Q45282927 description "জুন ২০১৩-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q45282927 description "บทความทางวิทยาศาสตร์" @default.
- Q45282927 description "სამეცნიერო სტატია" @default.
- Q45282927 name "Phase II study of a triple combination of oral vinorelbine, capecitabine and trastuzumab as first-line treatment in HER2-positive metastatic breast cancer" @default.
- Q45282927 name "Phase II study of a triple combination of oral vinorelbine, capecitabine and trastuzumab as first-line treatment in HER2-positive metastatic breast cancer" @default.
- Q45282927 type Item @default.
- Q45282927 label "Phase II study of a triple combination of oral vinorelbine, capecitabine and trastuzumab as first-line treatment in HER2-positive metastatic breast cancer" @default.
- Q45282927 label "Phase II study of a triple combination of oral vinorelbine, capecitabine and trastuzumab as first-line treatment in HER2-positive metastatic breast cancer" @default.
- Q45282927 prefLabel "Phase II study of a triple combination of oral vinorelbine, capecitabine and trastuzumab as first-line treatment in HER2-positive metastatic breast cancer" @default.
- Q45282927 prefLabel "Phase II study of a triple combination of oral vinorelbine, capecitabine and trastuzumab as first-line treatment in HER2-positive metastatic breast cancer" @default.
- Q45282927 P1433 Q45282927-35FF3F68-4DC2-4E20-8588-AC73EC70DD0F @default.
- Q45282927 P1476 Q45282927-CAF92473-20A2-4BAA-A915-178EEB7FAAB5 @default.
- Q45282927 P2093 Q45282927-0DEAD036-4E2D-4082-8E92-D6BC7479A785 @default.
- Q45282927 P2093 Q45282927-0FFEF74C-9BAE-42A1-B230-AF913BEF6754 @default.
- Q45282927 P2093 Q45282927-24B52476-02F4-4B06-8EFE-663490238F60 @default.
- Q45282927 P2093 Q45282927-4DBEE800-139C-4A3B-9032-8908CEBDAFB3 @default.
- Q45282927 P2093 Q45282927-690D7FC5-8BE0-4C78-A763-71DDB0F46BDE @default.
- Q45282927 P2093 Q45282927-7F1C1B16-64C5-40D4-98C1-6855C9DB0985 @default.
- Q45282927 P2093 Q45282927-A983AC3F-D60D-46D3-A001-087E98C7F7C3 @default.
- Q45282927 P2093 Q45282927-D51DEA88-018B-4C8E-B452-1CB4F983F2C5 @default.
- Q45282927 P2093 Q45282927-EA272811-D43A-46A2-A0AC-10BCDDE975EE @default.
- Q45282927 P2093 Q45282927-EA9A2503-2A40-4611-B50E-CA916BF7A48E @default.
- Q45282927 P2093 Q45282927-EEDAC8ED-05FA-41CF-B767-B577255C5A03 @default.
- Q45282927 P304 Q45282927-FDFB4E91-30C2-477C-8416-0EE6417E72D4 @default.
- Q45282927 P31 Q45282927-61CA0094-14DC-4FD2-AE6B-4228078D1211 @default.
- Q45282927 P407 Q45282927-66DAB953-940C-4F99-9120-FBCFA2E8E851 @default.
- Q45282927 P433 Q45282927-0DBF3920-8C38-4B6E-AFD1-E4D4142EA4EA @default.
- Q45282927 P478 Q45282927-2273CF15-92C4-4995-8907-B1CEF37519D4 @default.
- Q45282927 P50 Q45282927-F7C154BD-1C29-4243-A8ED-7EB0F277D93A @default.
- Q45282927 P577 Q45282927-5A4BF3C6-CB00-49B5-B65F-1230319750A4 @default.
- Q45282927 P698 Q45282927-CD5D61C5-014A-425D-A940-386DF5FE63AB @default.
- Q45282927 P921 Q45282927-E33C4791-7A6A-4B1E-AA89-5A13ED73A27B @default.
- Q45282927 P921 Q45282927-F92AA518-90D5-4F3E-924B-616A8BDAEA6D @default.
- Q45282927 P698 23749924 @default.
- Q45282927 P1433 Q326290 @default.
- Q45282927 P1476 "Phase II study of a triple combination of oral vinorelbine, capecitabine and trastuzumab as first-line treatment in HER2-positive metastatic breast cancer" @default.
- Q45282927 P2093 "Antonio Llombart" @default.
- Q45282927 P2093 "Arlene Chan" @default.
- Q45282927 P2093 "Françoise Majois" @default.
- Q45282927 P2093 "Gustavo Villanova" @default.
- Q45282927 P2093 "Lubos Petruzelka" @default.
- Q45282927 P2093 "Marc Espie" @default.
- Q45282927 P2093 "Miguel Gil Gil" @default.
- Q45282927 P2093 "Nathalie Vaissiere" @default.
- Q45282927 P2093 "Nicole Tubiana-Mathieu" @default.